Press Releases

Chronic and rare kidney disease drug development has been heating up as stakeholders bustle to deliver benefits beyond SGLT2s.  Already in January 2021, Bayer and AstraZeneca have been…
Read More...

Following the FDA’s approval of 12 personalised medicines and 7 diagnostics in 2019, then a record number of precision oncology drugs in H1 2020, demand is high for Dx-enabled therapies…
Read More...

With the global oligonucleotide therapeutics market forecasted to climb to a record value of 7 billion dollars in the next 3 years, a rapidly increasing volume of FDA approvals and…
Read More...

AI Driven Drug Repositioning and Repurposing Summit taking place April 20-21, is an exciting online event which shines a light on the benefits of AI tools in drug repurposing and helps…
Read More...

Join our ground-breaking new conference dedicated to drive forward the development of effective therapies for chronic fibrosing ILDs. The ILD Summit takes place this April 27-29,…
Read More...

SMi Reports: Hear key Sessions from Amgen, BSI, FDA, Biogen, Takeda, Janssen, Merck, Alexion Pharmaceuticals, Regeneron Pharmaceuticals and many more! The two-day conference agenda…
Read More...

The fully launched MAH and priority review pathways from the NMPA (National Medical Products Administration) is stimulating new demand in China for 2021. The recently hosted CPhI…
Read More...

SMi Reports: The only B2B parallel trade conference in Europe This conference will bring together industry experts to discuss the challenges and drivers of the industry, including…
Read More...

SMi Reports: The Virtual conference now only 2 weeks away The upcoming virtual conference now only 2 weeks away will bring together industry experts from leading RNA therapeutics…
Read More...

SMi Group Reports: Six key microbiology presentations from FDA, STERIS, Boehringer Ingelheim Microbiological Consulting, Parexel will be discussed at SMi’s 4th Annual Pharmaceutical…
Read More...

SMi Reports: The Injectable Drug Delivery Conference returns as a virtual event on 12th and 13th May 2021 Part of Europe’s leading Injectable conference series, we will assess…
Read More...

SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 2nd Annual AI in Drug Discovery Conference taking place on 15 and 16h March 2021 as a virtual…
Read More...

SMi Reports: 8th annual Pre-Filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. Pre-Filled Syringes East Coast 2021 for your chance to network…
Read More...

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade As part of the 15th annual Parallel Trade conference. The two-day…
Read More...

SMi Reports: Innovations in technologies and applications of RNA-based medicine We have witnessed significant growth and innovation in the RNA market. The 2-day agenda for the…
Read More...

SMi Reports: Conference Chairman invite letter released for SMi’s 5th Annual 3D Cell Culture Virtual Conference, taking place in February 2021. SMi’s 5th Annual 3D Cell Culture will…
Read More...

SMi Reports: Pre-filled Syringes Europe Conference taking place on the 13th – 14th January 2021. The upcoming virtual conference now only 2 weeks away will bring you the key insights…
Read More...

SMi Reports: Speaker interview released for SMi’s 2nd Annual AI in Drug Discovery Conference taking place on 15 – 16 March 2021 as a virtual conference with online access only.…
Read More...

SMi Reports: The 8th annual Pre-filled Syringes East Coast conference is returning as a virtually conference on April 26th – 27th 2021. SMi Group are delighted to have Susan Neadle,…
Read More...

SMi Reports: Speaker interview from AstraZeneca released ahead of SMi’s 5th Annual 3D Cell Culture taking place on 10 – 11 February 2021 as a virtual conference with online access only.…
Read More...